Chinook Therapeutics, Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7ac06715-022a-48a3-b713-d759f08b487d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-185.1M | 2022-01-01 – 2022-12-31 | evidence 0001564590-23-002589 |
| FY 2021 | $-99.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010862 |
| FY 2020 | $-56.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-018017 |
| FY 2019 | $-20.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-018017 |
| FY 2018 | $-101.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004942 |
| FY 2017 | $-106.5M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004135 |
| FY 2016 | $-71.9M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003099 |
| FY 2015 | $-13.6M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014215 |
| FY 2014 | $-19.1M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-014215 |
| FY 2013 | $-14.5M | 2013-01-01 – 2013-12-31 | evidence 0001564590-16-014215 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Chinook Therapeutics, Inc. — all facts · Revenue · Net Income